Does ENZALUTAMIDE Cause Pulmonary embolism? 114 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 114 reports of Pulmonary embolism have been filed in association with ENZALUTAMIDE (Xtandi). This represents 0.2% of all adverse event reports for ENZALUTAMIDE.
114
Reports of Pulmonary embolism with ENZALUTAMIDE
0.2%
of all ENZALUTAMIDE reports
39
Deaths
67
Hospitalizations
How Dangerous Is Pulmonary embolism From ENZALUTAMIDE?
Of the 114 reports, 39 (34.2%) resulted in death, 67 (58.8%) required hospitalization, and 9 (7.9%) were considered life-threatening.
Is Pulmonary embolism Listed in the Official Label?
Yes, Pulmonary embolism is listed as a known adverse reaction in the official FDA drug label for ENZALUTAMIDE.
What Other Side Effects Does ENZALUTAMIDE Cause?
Fatigue (8,891)
Death (6,680)
Malignant neoplasm progression (4,696)
Prostatic specific antigen increased (3,731)
Asthenia (3,589)
Drug ineffective (3,468)
Hot flush (3,144)
Decreased appetite (3,069)
Nausea (2,898)
Dizziness (2,776)
What Other Drugs Cause Pulmonary embolism?
RIVAROXABAN (3,282)
LENALIDOMIDE (2,976)
APIXABAN (2,714)
ETHINYL ESTRADIOL\ETONOGESTREL (2,370)
TESTOSTERONE (2,043)
RITUXIMAB (1,764)
ADALIMUMAB (1,663)
PREDNISONE (1,586)
METHOTREXATE (1,508)
DEXAMETHASONE (1,336)
Which ENZALUTAMIDE Alternatives Have Lower Pulmonary embolism Risk?
ENZALUTAMIDE vs EPCORITAMAB
ENZALUTAMIDE vs EPCORITAMAB-BYSP
ENZALUTAMIDE vs EPERISONE
ENZALUTAMIDE vs EPHEDRINE
ENZALUTAMIDE vs EPINASTINE